HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kiyohiro Ando Selected Research

PF 00477736

1/2020CEP131 Abrogates CHK1 Inhibitor-Induced Replication Defects and Is Associated with Unfavorable Outcome in Neuroblastoma.
7/2019Co-Inhibition of the DNA Damage Response and CHK1 Enhances Apoptosis of Neuroblastoma Cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kiyohiro Ando Research Topics

Disease

15Neoplasms (Cancer)
02/2022 - 08/2004
7Neuroblastoma
02/2022 - 06/2004
4Pancreatic Neoplasms (Pancreatic Cancer)
01/2021 - 10/2017
2Carcinoma (Carcinomatosis)
02/2022 - 06/2004
2Urinary Bladder Neoplasms (Bladder Cancer)
02/2021 - 09/2019
2Stomach Neoplasms (Stomach Cancer)
02/2021 - 09/2019
1Parotid Neoplasms
02/2021
1Melanoma (Melanoma, Malignant)
02/2021
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
02/2021
1Carcinogenesis
10/2019
1Ataxia Telangiectasia (Louis Bar Syndrome)
07/2019
1Lung Neoplasms (Lung Cancer)
11/2008
1Osteosarcoma (Osteogenic Sarcoma)
02/2008
1Starvation
02/2008
1Breast Neoplasms (Breast Cancer)
08/2006
1Hepatoblastoma
08/2004

Drug/Important Bio-Agent (IBA)

5Messenger RNA (mRNA)IBA
02/2022 - 06/2004
4Proteins (Proteins, Gene)FDA Link
01/2021 - 06/2004
3DNA (Deoxyribonucleic Acid)IBA
11/2021 - 11/2008
2PF 00477736IBA
01/2020 - 07/2019
2Phosphotransferases (Kinase)IBA
07/2019 - 06/2004
2Glucose (Dextrose)FDA LinkGeneric
12/2009 - 02/2008
2ElementsIBA
12/2009 - 09/2008
1Hemoglobins (Hemoglobin)IBA
02/2022
1AlbuminsIBA
02/2022
1Type 2 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 2)IBA
02/2022
1pembrolizumabIBA
02/2022
1B7-H1 AntigenIBA
02/2021
1Polymeric Immunoglobulin Receptors (Polymeric Immunoglobulin Receptor)IBA
01/2020
1Protein Isoforms (Isoforms)IBA
10/2019
1Tretinoin (Retinoic Acid)FDA LinkGeneric
10/2019
1Immune Checkpoint InhibitorsIBA
09/2019
1Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA
07/2019
1Cell-Free Nucleic AcidsIBA
10/2017
1Biomarkers (Surrogate Marker)IBA
10/2017
1AgarIBA
12/2013
1CarbonIBA
12/2009
1Carrier Proteins (Binding Protein)IBA
12/2009
1AMP-Activated Protein KinasesIBA
12/2009
1Cell Adhesion Molecule-1IBA
11/2008
1Immunoglobulins (Immunoglobulin)IBA
11/2008
1Small Interfering RNA (siRNA)IBA
09/2008
1Pharmaceutical PreparationsIBA
08/2006
1Doxorubicin (Adriamycin)FDA LinkGeneric
08/2006
1alpha-Fetoproteins (alpha-Fetoprotein)IBA
08/2004
1Indicators and Reagents (Reagents)IBA
08/2004
1beta CateninIBA
08/2004
1Cisplatin (Platino)FDA LinkGeneric
06/2004

Therapy/Procedure

3Therapeutics
02/2021 - 09/2019
2Aftercare (After-Treatment)
01/2020 - 09/2019
1Precision Medicine
01/2021
1Drug Therapy (Chemotherapy)
01/2020